"10.1371_journal.pone.0050541","plos one","2012-11-27T00:00:00Z","Christoph Campregher; Gerald Schmid; Franziska Ferk; Siegfried Knasmüller; Vineeta Khare; Benedikt Kortüm; Kyle Dammann; Michaela Lang; Theresa Scharl; Andreas Spittler; Andres I Roig; Jerry W Shay; Christopher Gerner; Christoph Gasche","Christian Doppler Laboratory for Molecular Cancer Chemoprevention, Division of Gastroenterology and Hepatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria; ACIB GmbH, c/o Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria; Department of Statistics and Probability Theory, University of Technology, Vienna, Austria; Department of Surgery, Research Laboratories & Core Facility Flow Cytometry, Medical University of Vienna, Vienna, Austria; Department of Cell Biology, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria","Conceived and designed the experiments: CC C. Gasche GS C. Gerner VK. Performed the experiments: CC C. Gerner GS BK FF AS KD ML. Analyzed the data: CC TS FF SK C. Gerner. Contributed reagents/materials/analysis tools: AIR JWS. Wrote the paper: CC.","CG has ongoing research collaborations with AOP Orphan Pharmaceuticals, Biogena Naturstoffe GmbH, and Shire Pharmaceuticals, and received research support, lecturing or consulting honoraria from AstraZeneca Austria, Ferring Int., Dr. Falk Pharma, Fresenius Medical Care, Minos Medical Inc., Pharmacosmos A/S, Renapharma Sweden, Shire Inc., Vifor Int., and Vifor Österreich. This does not alter the authors' adherence to the PLOS ONE policies on sharing data and materials.","2012","11","Christoph Campregher","CC",14,TRUE,2,2,5,1,TRUE,TRUE,TRUE,6,"2;5;6;7;8;10",TRUE
